A major trial of a promising gene therapy for Duchenne muscular dystrophy has fallen short, but researchers say the lessons learned could pave the way for better, more effective treatments.

A pause to NIH funding has researchers scrambling for contingency plans at the University of Washington’s Alzheimer’s Disease ...

Curious what recovery really looks like after a hip replacement? Dr. Ayesha Abdeen, chief of hip and knee replacement surgery ...

Studies show music therapy in the NICU provides a host of benefits, including a stabilized heart rate and improved breathing, ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

The largest study to date suggests that patients at high risk for heart attacks and strokes should begin immediate treatment with a combination of a statin and ezetimibe. The largest study to date exa ...

Overthinking, although it may appear to be beneficial in many ways, is based on a high degree of self-importance, which, ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

Blumhouse’s latest revives the spirit of 2000s thrillers for a new generation, with a lead who doesn't need any saving.

The 1950s was a turning point for polio. Amid deadly outbreaks, Jonas Salk developed a vaccine that saved countless lives ...

Members of the Our Place Parkinson’s support group learned about a newly approved therapy offering more consistent symptom ...

Heparin is cheap and essential to millions of hospitalized people. Tariffs could disrupt the supply chain that gets ...